Pablo Catalá

547 total citations
15 papers, 139 citations indexed

About

Pablo Catalá is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Neurology. According to data from OpenAlex, Pablo Catalá has authored 15 papers receiving a total of 139 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Infectious Diseases and 6 papers in Neurology. Recurrent topics in Pablo Catalá's work include COVID-19 Clinical Research Studies (7 papers), Long-Term Effects of COVID-19 (6 papers) and Cardiac Valve Diseases and Treatments (5 papers). Pablo Catalá is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), Long-Term Effects of COVID-19 (6 papers) and Cardiac Valve Diseases and Treatments (5 papers). Pablo Catalá collaborates with scholars based in Spain. Pablo Catalá's co-authors include Ignacio J. Amat‐Santos, J. Alberto San Román, Manuel Carrasco‐Moraleja, Álvaro Aparisi, Diego López‐Otero, Aitor Uribarri, Borja Ibáñez, Javier Castrodeza, Luis Nombela‐Franco and Enrique Gutiérrez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Pablo Catalá

13 papers receiving 135 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Catalá Spain	6	84	63	51	37	25	15	139
José Raúl Delgado-Arana Spain	5	42 0.5×	64 1.0×	25 0.5×	44 1.2×	6 0.2×	8	103
Fabiana D’Amico Italy	5	54 0.6×	24 0.4×	53 1.0×	18 0.5×	6 0.2×	7	100
Renata Moll‐Bernardes Brazil	6	89 1.1×	60 1.0×	59 1.2×	36 1.0×	15 0.6×	19	157
Érika Muñoz-García Spain	4	42 0.5×	36 0.6×	25 0.5×	18 0.5×	6 0.2×	7	81
Matthieu Pecquet France	5	77 0.9×	13 0.2×	30 0.6×	21 0.6×	11 0.4×	9	137
Riccardo Mantovani Italy	5	38 0.5×	36 0.6×	16 0.3×	6 0.2×	19 0.8×	13	76
Nicholas W. Lange United States	9	84 1.0×	18 0.3×	21 0.4×	37 1.0×	12 0.5×	20	203
Mathew Jones United States	5	51 0.6×	14 0.2×	44 0.9×	21 0.6×	10 0.4×	13	109
Jonas Herzberg United Arab Emirates	7	72 0.9×	21 0.3×	12 0.2×	10 0.3×	16 0.6×	21	132
Bunny Saberwal United Kingdom	9	23 0.3×	124 2.0×	14 0.3×	19 0.5×	14 0.6×	19	162

Countries citing papers authored by Pablo Catalá

Since Specialization

Citations

This map shows the geographic impact of Pablo Catalá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Catalá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Catalá more than expected).

Fields of papers citing papers by Pablo Catalá

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Catalá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Catalá. The network helps show where Pablo Catalá may publish in the future.

Co-authorship network of co-authors of Pablo Catalá

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Catalá. A scholar is included among the top collaborators of Pablo Catalá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Catalá. Pablo Catalá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Catalá, Pablo, et al.. (2025). Maintenance Immunosuppression With Tacrolimus and Everolimus in Heart Transplantation Compared With the Usual Tacrolimus and Micophenolate Protocol: Results From a Retrospective Registry. Transplantation Proceedings. 57(1). 59–66.

López‐Otero, Diego, Ignacio J. Amat‐Santos, Javier López País, et al.. (2021). The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients. Scientific Reports. 11(1). 9361–9361. 15 indexed citations

García-Granja, Pablo Elpidio, Carlos Alberto Gurgel Veras, Álvaro Aparisi, et al.. (2021). Atrial fibrillation in patients with SARS-CoV-2 infection. Medicina Clínica (English Edition). 157(2). 58–63. 3 indexed citations

García-Granja, Pablo Elpidio, Carlos Alberto Gurgel Veras, Álvaro Aparisi, et al.. (2021). Atrial fibrillation in patients with SARS-CoV-2 infection. Medicina Clínica. 157(2). 58–63. 15 indexed citations

Aparisi, Álvaro, Javier Tobar, Aitor Uribarri, et al.. (2021). Post-COVID-19 syndrome: prospective evaluation of clinical and functional outcomes. European Heart Journal. 42(Supplement_1).

Amat‐Santos, Ignacio J., Sandra Santos‐Martínez, Pablo Catalá, et al.. (2020). Impact of renin-angiotensin system inhibitors on outcomes after surgical or transcatheter aortic valve replacement. A meta-analysis. Revista Española de Cardiología (English Edition). 74(5). 421–426. 3 indexed citations

Amat‐Santos, Ignacio J., Sandra Santos‐Martínez, Diego López‐Otero, et al.. (2020). Ramipril in High-Risk Patients With COVID-19. Journal of the American College of Cardiology. 76(3). 268–276. 49 indexed citations

Román, J. Alberto San, Aitor Uribarri, Ignacio J. Amat‐Santos, et al.. (2020). The presence of heart disease worsens prognosis in patients with COVID-19. Revista Española de Cardiología (English Edition). 73(9). 773–775. 10 indexed citations

Román, J. Alberto San, Aitor Uribarri, Ignacio J. Amat‐Santos, et al.. (2020). La presencia de cardiopatía agrava el pronóstico de los pacientes con COVID-19. Revista Española de Cardiología. 73(9). 773–775. 5 indexed citations

10.

Amat‐Santos, Ignacio J., Sandra Santos‐Martínez, Pablo Catalá, et al.. (2020). Impacto de los inhibidores del sistema renina-angiotensina en el pronóstico tras recambio valvular aórtico quirúrgico o percutáneo. Metanálisis. Revista Española de Cardiología. 74(5). 421–426. 2 indexed citations

11.

Cortés, Carlos, Tania Rodríguez‐Gabella, Hipólito Gutiérrez, et al.. (2019). Quantitative flow ratio in myocardial infarction for the evaluation of non-infarct-related arteries. The QIMERA pilot study. SHILAP Revista de lepidopterología. 3 indexed citations

12.

Catalá, Pablo, Ignacio J. Amat‐Santos, Manuel Carrasco‐Moraleja, et al.. (2019). El Multivalvular Score para predecir la evolución de la insuficiencia mitral en pacientes con estenosis aórtica tratados con TAVI: validación prospectiva. Revista Española de Cardiología. 72(9). 781–783. 1 indexed citations

13.

Cortés, Carlos, Pablo Catalá, Hipólito Gutiérrez, et al.. (2018). TCT-872 Quantitative Flow RatIo in Myocardial Infarction for the Evaluation of Non-Infart Related Arteries: The QIMERA Pilot Study. Journal of the American College of Cardiology. 72(13). B347–B348. 1 indexed citations

14.

Catalá, Pablo, Ignacio J. Amat‐Santos, Manuel Carrasco‐Moraleja, et al.. (2018). The Multivalvular Score for Predicting the Outcome of Mitral Regurgitation in Aortic Stenosis Patients Treated With TAVI: Prospective Validation. Revista Española de Cardiología (English Edition). 72(9). 781–783. 1 indexed citations

15.

Amat‐Santos, Ignacio J., Hipólito Gutiérrez, Javier Castrodeza, et al.. (2018). Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral. Catheterization and Cardiovascular Interventions. 92(5). 935–944. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact